Ritual Perimenopause Health: Label and Evidence

Four actives, one capsule, and no finished-product trial yet. The shatavari dose matches trials of other extracts; the rest is thinner.

Dose fit	Mixed. 100 mg shatavari matches doses in trials of different standardized extracts; 60 mg DIM is below the 75 mg used in a metabolism trial, not a symptom trial; the label does not show which human symptom studies used 250 mg evening primrose or 0.9 mg B6.
Evidence fit	No finished-product trial found. Evidence is for separate ingredients, and Ritual does not publicly identify the shatavari extract brand, ratio or shatavarin percentage on the label.
Safety flags	Check with a clinician before use with hormone therapy, hormonal contraception, tamoxifen, anticoagulants or antiplatelets, or with hormone-sensitive history, pregnancy, trying to conceive, breastfeeding, liver disease or medicines metabolized by CYP enzymes.
The negative case	The best evidence is for shatavari extracts that cannot be confirmed as the one in Ritual's capsule. The finished blend has not been tested, and Ritual's other active ingredients do not have a clean dose-and-outcome match for perimenopause symptoms.

If the Perimenopause Health label looks reassuringly tidy, pause at the fine print. Four active ingredients fit in one capsule. That is not the same as four ingredients shown to work together at those doses.

In short

Ritual’s September 15 launch pairs 100 mg shatavari root extract with 60 mg DIM, 0.9 mg vitamin B6 and 250 mg evening primrose oil. Shatavari has human perimenopause studies at 100 mg, but they used other extracts that Ritual does not publicly identify. The other ingredients have thinner evidence. No finished-product trial was available at launch. This is a label-and-evidence read, not medical advice.

What Ritual claims

Ritual calls the product “hormone-free” and says it supports hormone balance, estrogen metabolism and perimenopause symptoms. The launch release attributes mood, hot-flash, night-sweat, sleep, vaginal-dryness and fatigue support to its shatavari extract. It says evening primrose may help hot flashes and supports DIM absorption, while B6 may support mood. Those are company claims, not FDA findings. Ritual also says the capsule contains no added synthetic hormones. [1]

“Hormone-free” means no hormones were added. It does not prove that the ingredients cannot affect hormone pathways or that the blend works.

The label, ingredient by ingredient

Active	Ritual amount	Evidence fit
Shatavari root extract	100 mg	Perimenopause trials exist at 100 mg, but not of a publicly identified Ritual extract.
DIM	60 mg	Human studies mostly measure estrogen metabolites, not symptoms. A 75 mg trial missed its main metabolite-ratio endpoint.
Vitamin B6 as pyridoxal-5-phosphate	0.9 mg	No relevant randomized perimenopause trial at this dose was found.
Evening primrose seed oil	250 mg	Reviews say hot-flash evidence is insufficient; studied doses were commonly higher.

Ritual’s product page lists those amounts in one vegan capsule and 30 servings per container. [2] The public label does not name the shatavari supplier, extract ratio or percentage of shatavarins. That is a major identity gap. “100 mg shatavari extract” is not automatically equivalent to the extract used in a trial.

Shatavari: close, but not confirmed

A 2025 trial assigned 75 women aged 40–50 with mild-to-moderate vasomotor symptoms to placebo, 50 mg or 100 mg of CL22209, a proprietary extract standardized to at least 15% total shatavarins. After 120 days, both doses improved menopause and hot-flash scores versus placebo; no serious adverse events were reported. [3] A separate 2026 trial used 100 mg SheVari4, standardized to at least 5% shatavarin IV, in 60 women spanning pre-, peri- and postmenopause. It also reported improved symptom scores, but it was small and single-center. Neither paper identifies SheVari4 or CL22209 as Ritual’s extract. [4]

The dose fits. The exact material remains unproven. Our shatavari explainer explains why extract identity is not a technicality.

DIM: metabolism, not symptom relief

DIM can change estrogen-metabolite patterns. That is a laboratory result, not proof of fewer hot flashes. In a randomized trial of 60 premenopausal women, 75 mg DIM for 30 days did not significantly improve the prespecified urinary 2-OHE1/16α-OHE1 ratio. Ritual supplies 60 mg, which was not tested there and is not a symptom dose. [5]

Memorial Sloan Kettering says human evidence is limited and warns about hormonal effects and drug metabolism. It advises pregnant, nursing, trying-to-conceive, or hormonal-contraception users to consult a clinician and flags possible interactions with CYP450- and MDR1-substrate drugs. Serious case reports do not prove DIM caused them, but they increase the case for medical review. [6] See our DIM explainer before combining products.

B6 and evening primrose: weak links

The label gives 0.9 mg B6. We found no relevant randomized perimenopause trial at that dose. This is an evidence-fit issue, not a toxicity red flag by itself: the NIH adult upper limit is 100 mg per day from all sources. [7]

Evening primrose supplies 250 mg. A 2025 systematic review found no significant difference versus placebo for hot-flash frequency or duration and said firm conclusions could not be drawn. NCCIH also says evidence is insufficient for menopause symptoms, while noting short-term use is probably safe for most adults. [8][9] The oil may be a delivery fat for DIM, but that does not rescue the symptom evidence.

The receipts, plainly

Claimed: broad hormone-balance and symptom support from a “clinically studied” blend. [1]
On label: shatavari 100 mg, DIM 60 mg, B6 0.9 mg and evening primrose 250 mg. [2]
Dose fit: shatavari is a dose match but not a confirmed extract match. The other three lack a clean dose-population-outcome match.
Evidence fit: no trial of the finished product was found. Ritual’s promise to test all finished products by 2030 is not evidence for this launch. [1]
Safety flags: clinician review is sensible with hormone therapy, hormonal contraception, tamoxifen, blood thinners, hormone-sensitive history, pregnancy-related concerns, liver disease, or medicines affected by CYP enzymes. [6][10]
Real cost: $39 for 30 capsules, or $1.30 per day, at launch. Ritual sells recurring subscriptions. [1]
Negative case: the best evidence belongs to shatavari extracts that may not match Ritual’s; the blend is untested; and the supporting actives are weak fits.

What the formula omits

This is a focused supplement, not a menopause multivitamin. It adds no vitamin D, calcium, magnesium, vitamin E, omega-3, fiber or protein. That is not automatically a flaw. It is a scope check: the capsule was not built to cover bone nutrition, heart nutrition or gut regularity.

The negative case

The clearest concern is uncertainty, not an excessive dose. Paying $39 monthly buys a good shatavari dose and Ritual’s traceability certifications, not proof of the blend. If your main goal is sleep, bone health or vaginal symptoms, this short label does not show that those outcomes were tested together.

The missing receipt is finished-product data: identity-matched shatavari, 60 mg DIM, 0.9 mg B6 and 250 mg evening primrose in one capsule, tested against placebo in perimenopausal women.

Until then, the label supports a sensible audit. It does not support calling the combination clinically proven.